Last update Dec. 7, 2022
Compatible
We do not have alternatives for Ασενοκουμαρόλη , νικουμαλόνη since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Ασενοκουμαρόλη , νικουμαλόνη is Acenocoumarol in Greek.
Is written in other languages:Ασενοκουμαρόλη , νικουμαλόνη is also known as
Ασενοκουμαρόλη , νικουμαλόνη belongs to this group or family:
Main tradenames from several countries containing Ασενοκουμαρόλη , νικουμαλόνη in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 60 | % |
Molecular weight | 353 | daltons |
Protein Binding | 99 | % |
VD | 0.08 | l/Kg |
pKa | 5.09 | - |
Tmax | 1 - 3 | hours |
T½ | 8 - 11 | hours |
Theoretical Dose | 0.002 | mg/Kg/d |
Relative Dose | 1 | % |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Coumarin-type anticoagulant drug vitamin K antagonist with actions similar to those of warfarin used for the treatment and prophylaxis of thromboembolic disorders. It works by depressing the hepatic synthesis of vitamin K-dependent coagulation factors.Oral administration.
Its high plasma protein-binding capacity would explain the very low excretion observed into breast milk. (Houwert-de Jong 1981, Nava 2004)
No clinical side-effects and/or blood test disarrangements were observed in infants whose mothers were treated with acenocoumarol. (Houwert-de Jong 1981, Fondevila 1989)
Several medical societies and experts authors consider the use of this medication to be safe or very probably safe during breastfeeding. (Bates 2018, 2012 & 1997, Middeldorp 2011, Clark 2000, Olthof 1993)